Reduced indinavir exposure during pregnancy
Aim: To describe the pharmacokinetics and safety of indinavir boosted with ritonavir (IDV/r) during the second and third trimesters of pregnancy and in the post-partum period. Methods: IMPAACT P1026s is an on-going, prospective, non-blinded study of antiretroviral pharmacokinetics (PK) in HIV-infect...
Saved in:
Main Authors: | Tim R. Cressey, Brookie M. Best, Jullapong Achalapong, Alice Stek, Jiajia Wang, Nantasak Chotivanich, Prapap Yuthavisuthi, Pornnapa Suriyachai, Sinart Prommas, David E. Shapiro, D. Heather Watts, Elizabeth Smith, Edmund Capparelli, Regis Kreitchmann, Mark Mirochnick |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84882644760&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52824 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Reduced indinavir exposure during pregnancy
by: Tim R. Cressey, et al.
Published: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
by: Regis Kreitchmann, et al.
Published: (2019) -
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
by: Tim R. Cressey, et al.
Published: (2018) -
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
by: Tim R. Cressey, et al.
Published: (2018) -
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
by: Tim R. Cressey, et al.
Published: (2018)